Detalles de la búsqueda
1.
Spectral Topography of the Subthalamic Nucleus to Inform Next-Generation Deep Brain Stimulation.
Mov Disord
; 38(5): 818-830, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36987385
2.
Fertility specialists' views, behavior, and attitudes towards the use of endometrial scratching in Italy.
BMC Womens Health
; 23(1): 397, 2023 07 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37516869
3.
Targeting CD205 with the antibody drug conjugate MEN1309/OBT076 is an active new therapeutic strategy in lymphoma models.
Haematologica
; 105(11): 2584-2591, 2020 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33131247
4.
Single and combined BTK and PI3Kδ inhibition with acalabrutinib and ACP-319 in pre-clinical models of aggressive lymphomas.
Br J Haematol
; 187(5): 595-601, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31355927
5.
Bromodomain and extra-terminal domain inhibition modulates the expression of pathologically relevant microRNAs in diffuse large B-cell lymphoma.
Haematologica
; 103(12): 2049-2058, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30076183
6.
Preclinical evaluation of the BET bromodomain inhibitor BAY 1238097 for the treatment of lymphoma.
Br J Haematol
; 178(6): 936-948, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28653353
7.
The novel atypical retinoid ST5589 down-regulates Aurora Kinase A and has anti-tumour activity in lymphoma pre-clinical models.
Br J Haematol
; 171(3): 378-86, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26235926
8.
Clinical neurophysiological interrogation of motor slowing: A critical step towards tuning adaptive deep brain stimulation.
Clin Neurophysiol
; 152: 43-56, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37285747
9.
Does Subthalamic Deep Brain Stimulation Impact Asymmetry and Dyscoordination of Gait in Parkinson's Disease?
Neurorehabil Neural Repair
; 35(11): 1020-1029, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34551639
10.
Understanding the mechanism of action of pyrrolo[3,2-b]quinoxaline-derivatives as kinase inhibitors.
RSC Med Chem
; 11(6): 665-675, 2020 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33479666
11.
BET bromodomain inhibitor birabresib in mantle cell lymphoma: in vivo activity and identification of novel combinations to overcome adaptive resistance.
ESMO Open
; 3(6): e000387, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30305939
12.
PQR309 Is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in Lymphomas as a Single Agent and in Combination Therapy.
Clin Cancer Res
; 24(1): 120-129, 2018 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29066507
13.
Assessment of the Antiproliferative Activity of a BET Bromodomain Inhibitor as Single Agent and in Combination in Non-Hodgkin Lymphoma Cell Lines.
Methods Mol Biol
; 1436: 305-12, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27246223
14.
Bromodomain inhibitor OTX015 (MK-8628) combined with targeted agents shows strong in vivo antitumor activity in lymphoma.
Oncotarget
; 7(36): 58142-58147, 2016 Sep 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27494885
15.
Preclinical antitumor activity of ST7612AA1: a new oral thiol-based histone deacetylase (HDAC) inhibitor.
Oncotarget
; 6(8): 5735-48, 2015 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-25671299
16.
DNA-mediated adjuvant immunotherapy extends survival in two different mouse models of myeloid malignancies.
Oncotarget
; 6(32): 32494-508, 2015 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-26378812
17.
The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs.
Clin Cancer Res
; 21(7): 1628-38, 2015 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25623213
Resultados
1 -
17
de 17
1
Próxima >
>>